Extent of Thyroidectomy and Lymphadenectomy in 254 Patients With Papillary Thyroid Microcarcinoma: A Single-Institution Experience

被引:36
作者
Besic, Nikola [1 ]
Zgajnar, Janez [1 ]
Hocevar, Marko [1 ]
Petric, Rok [1 ]
机构
[1] Inst Oncol Ljubljana, Dept Surg Oncol, SI-1000 Ljubljana, Slovenia
关键词
LYMPH-NODE DISSECTION; PROGNOSTIC-FACTORS; METASTASIS; CARCINOMA; STRATEGY; TUMORS;
D O I
10.1245/s10434-009-0332-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
No agreement has been made about the optimal extent of thyroidectomy or lymph node dissection in papillary thyroid microcarcinoma (PTMC). Our aim was to find out the factors associated with the presence of lymph node metastases in the patients with PTMC and to discuss the extent of thyroidectomy and lymphadenectomy. A total of 254 patients with PTMC (212 women, 42 men; age 14 to 85 years, median 47 years) were treated at our institute between 1975 and 2007. Lymph node metastases were confirmed in 59 patients (23%) by histopathology. The median observation time was 56 (range, 1-397) months, and the recurrence was diagnosed in seven patients. Modified radical neck dissection and central neck dissection were performed in 55 and 30 patients, respectively. The data on the clinicopathological characteristics of patients and treatment were collected. An incidental PTMC was diagnosed in 107 patients postoperatively. In none of them was a lymph node metastasis or tumor recurrence detected. Preoperatively, an overt PTMC was diagnosed in 147 patients. Clinically manifest metastases were diagnosed in 59 (40%) of them: in 51 preoperatively, and in 8 during the surgical procedure. In 147 patients who had preoperative diagnosis of PTMC, the factors that correlated (P < 0.05) with the presence of lymph node metastases were sex, age, and tumor type. The patients with high-risk PTMC with preoperatively confirmed lymph node metastases had a higher recurrence rate than those with low-risk PTMC without preoperatively detectable lymph node metastases; therefore, careful therapeutic node dissection is necessary in high-risk patients.
引用
收藏
页码:920 / 928
页数:9
相关论文
共 32 条
[1]  
[Anonymous], 2002, TNM CLASSIFICATION M
[2]  
Appetecchia M, 2002, J EXP CLIN CANC RES, V21, P159
[3]  
Baudin E, 1998, CANCER, V83, P553, DOI 10.1002/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO
[4]  
2-U
[5]   Papillary thyroid microcarcinoma: Prognostic factors and treatment [J].
Besic, Nikola ;
Pilko, Gasper ;
Petric, Rok ;
Hocevar, Marko ;
Zgajnar, Janez .
JOURNAL OF SURGICAL ONCOLOGY, 2008, 97 (03) :221-225
[6]   What is the biology and optimal treatment for papillary microcarcinoma of the thyroid? [J].
Cheema, Yusra ;
Olson, Sarah ;
Elson, Diane ;
Chen, Herbert .
JOURNAL OF SURGICAL RESEARCH, 2006, 134 (02) :160-162
[7]   Papillary microcarcinoma of the thyroid - Prognostic significance of lymph node metastasis and multifocality [J].
Chow, SM ;
Law, SCK ;
Chan, JKC ;
Au, SK ;
Yau, S ;
Lau, WH .
CANCER, 2003, 98 (01) :31-40
[8]   Papillary thyroid carcinoma: Prognostic factors and the role of radioiodine and external radiotherapy [J].
Chow, SM ;
Law, SCK ;
Mendenhall, WM ;
Au, SK ;
Chan, PTM ;
Leung, TW ;
Tong, CC ;
Wong, ISM ;
Lau, WH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (03) :784-795
[9]  
ELIO R, 2008, EUR J ENDOCRINOL, V159, P659
[10]  
HAY ID, 1992, SURGERY, V112, P1139